Search
The Road to Motherhood: Simple Rules for Navigating Pregnancy in Primary Care
The PCP is the first line of care for women planning or beginning a pregnancy, and their questions range from “Which vitamins do I need?” to “Should I get genetic testing?”The Incidental Adrenal Mass: Workup Guide for a Common Finding
A frequent guest star on abdominal images taken to assess other conditions, an adrenal mass may be benign or serious, such as pheochromocytoma – making workup essential.The First Patient-Centered Sialadenitis Assessment Tool
A new standardized measure of symptoms associated with salivary duct obstruction was recently developed by researchers, including UCSF otolaryngologists Jolie Chang, MD, FACS, and William R. Ryan, MD, FACS, and UCSF medical student Arushi Gulati.Migraine Sufferers Are Prone to BPPV at an Earlier Age, Study Finds
Migraine predisposes individuals to developing benign paroxysmal positional vertigo (BPPV) earlier in life than those without migraine, according to a UCSF study.Advances in GI Cancer Care: How to Consider the Latest Drugs and Strategies
In this new edition of the Cancer Center Live Series, three UCSF specialists present exciting updates on difficult-to-treat gastrointestinal malignancies, including pancreatic cancer, peritoneal metastases and advanced biliary tract cancers.Renowned Expert to Lead UCSF’s Hematology and Oncology Division
Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology.UCSF Health Reaches 15,000 Robotic Surgeries
UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.New Hypoparathyroidism Guidelines and Emerging PTH Replacement Therapies for Improved Patient Outcomes
New guidelines from the Second International Workshop on the Evaluation and Management of Hypoparathyroidism provide clinicians with the latest evidence-based recommendations for the prevention, diagnosis and management of this rare disease.Lung Transplant Program
For nine consecutive years, the UCSF Lung Transplant Program has had significantly higher-than-expected post-surgery survival rates — the only program in the country with this record.What Matters Most to Patients Dealing With Stress Urinary Incontinence?
Many patients experience stress urinary incontinence (SUI) following surgical treatment for prostate cancer. To understand the impact of SUI on quality of life, a team of UCSF researchers interviewed and surveyed patients and published a series of studies.Advanced Heart Failure Clinic at Walnut Creek
Through a collaboration between John Muir Health and UCSF Health, patients with advanced heart failure have access to specialized care in Walnut Creek.New Method for Rapid, Intraoperative Detection of Residual Tumor Cells Can Vastly Improve Patient Outcomes
It is now possible to detect residual tumor cells during surgery within minutes, a groundbreaking advancement in the surgical treatment of tumors.Cerebral Cavernous Malformation Treatments Relieve Disparate Symptoms
Two patients with severe yet different neurological symptoms were referred to UCSF for emergent neurosurgical evaluation. Both were found to have previously undiagnosed cerebral cavernous malformations (CCMs), but each patient’s treatment was unique.Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future TherapiesTreating Severe Depression with On-Demand Brain Stimulation
UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.Autoantibody for Acquired Lipodystrophy Identified, Bringing Hope for Therapeutics
UCSF investigators have found an autoantibody biomarker for acquired lipodystrophy, paving the way for novel treatment options for this complex condition, which causes adipose tissue loss and metabolic complications.UCSF Prostate Cancer Program Awarded SPORE Grant by National Cancer Institute
The UCSF Prostate Cancer Program of the Helen Diller Family Comprehensive Cancer Center is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of Research Excellence (SPORE) grant for prostate cancer.How a Cutting-Edge Genetic Test Helps Ill Newborns, Pregnant Moms
UCSF is first in Northern California to offer rapid test in-house for faster and more accurate diagnosis of rare genetic conditions.Advances in Obesity Medicine: Better Bariatric Surgery Options and Outcomes
With obesity affecting 40% of the U.S. population, bariatric surgeon Jonathan Carter, MD, reviews the devastating health effects of excess body fat and contends that clinicians can no longer sidestep difficult conversations about weight management.Telehealth is as Safe as a Visit to the Clinic for Abortion Pills
Researchers analyzed data from more than 6,000 patients who obtained abortion pills from virtual clinics in 20 states and Washington D.C. between April of 2021 and January of 2022. They found there were no serious adverse events 99.8% of the time, and that abortions did not require follow-up care 98% of the time.Prominent Orthopaedic Surgeon and Researcher to Lead UCSF Orthopaedics Program
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma assumed his new role on January 1, 2024.New Research on Optimizing UC Management Through Patient-Centered Tofacitinib Dosing
Tofacitinib is effective for managing ulcerative colitis (UC) and is linked to sustained steroid-free remission. The product label recommends dose de-escalation after eight or 16 weeks, but is this best for patients?Advanced Heart Failure Evaluation and Therapies Program
A full range of therapeutic options – including evidence-based pharmacology, innovative devices and an experienced transplant program – offer personalized approaches to slow progression, prolong survival and improve quality of life